There is little information addressing the phenomena of discrepancy between minimal inhibitory concentrations (MIG) and minimal lethal concentrations (MLC) values of amphotericin B (AMB) to clinical isolates of fungi. This study assessed in vitro activity of AMB against 70 clinical isolates of aspergilli: 30 strains of Aspergillus fumigatus, 20 strains of Aspergillus flavus and 20 strains of Aspergillus niger. Susceptibility tests were accomplished using a macro broth dilution procedure, with special emphasis on ascertainment of MLCs. AMB exhibited low MIC values against all clinical isolates. While we did not identify any AMB resistant isolates among 70 Aspergillus spp. studied as judged by MIC levels, analysis of the data demonstrated a c...
Abstract OBJECTIVES: The aim of the present study was to evaluate the effects of amphotericin B (AMB...
A clear understanding of the pharmacodynamic properties of antifungal agents is important for the ad...
For filamentous fungi (moulds), species-specific interpretive breakpoints and epidemiological cut-of...
Conventional MIC testing of amphotericin B results in narrow MIC ranges challenging the detection of...
Conventional MIC testing of amphotericin B results in narrowMIC ranges challenging the detection of ...
Although there is evidence that liposomal amphotericin B (AmBisome) is non-inferior to amphotericin ...
Contains fulltext : 136894.pdf (publisher's version ) (Open Access)Although conven...
Candida auris is an emerging multiresistant yeast against which amphotericin B (AMB) is still the fi...
Item does not contain fulltextAspergillus terreus infections are difficult to treat because of the i...
Although guidelines for the treatment of Malassezia furfur fungemia are not yet defined, clinical da...
Item does not contain fulltextThe effect of the medium composition on the fungistatic (MIC) and fung...
Antifungal agents may differ in their fungicidal activities against Aspergillus spp. In order to com...
Póster presentado en 43rd Annual Interscience Conference on Antimicrobial Agents and Chemotherapy S...
<p>AMB – amphotericin B. The MICs of SM21 against the <i>Candida</i> isolates tested ranged from 0.2...
International audienceRecent studies have shown decreased susceptibility of Candida krusei to amphot...
Abstract OBJECTIVES: The aim of the present study was to evaluate the effects of amphotericin B (AMB...
A clear understanding of the pharmacodynamic properties of antifungal agents is important for the ad...
For filamentous fungi (moulds), species-specific interpretive breakpoints and epidemiological cut-of...
Conventional MIC testing of amphotericin B results in narrow MIC ranges challenging the detection of...
Conventional MIC testing of amphotericin B results in narrowMIC ranges challenging the detection of ...
Although there is evidence that liposomal amphotericin B (AmBisome) is non-inferior to amphotericin ...
Contains fulltext : 136894.pdf (publisher's version ) (Open Access)Although conven...
Candida auris is an emerging multiresistant yeast against which amphotericin B (AMB) is still the fi...
Item does not contain fulltextAspergillus terreus infections are difficult to treat because of the i...
Although guidelines for the treatment of Malassezia furfur fungemia are not yet defined, clinical da...
Item does not contain fulltextThe effect of the medium composition on the fungistatic (MIC) and fung...
Antifungal agents may differ in their fungicidal activities against Aspergillus spp. In order to com...
Póster presentado en 43rd Annual Interscience Conference on Antimicrobial Agents and Chemotherapy S...
<p>AMB – amphotericin B. The MICs of SM21 against the <i>Candida</i> isolates tested ranged from 0.2...
International audienceRecent studies have shown decreased susceptibility of Candida krusei to amphot...
Abstract OBJECTIVES: The aim of the present study was to evaluate the effects of amphotericin B (AMB...
A clear understanding of the pharmacodynamic properties of antifungal agents is important for the ad...
For filamentous fungi (moulds), species-specific interpretive breakpoints and epidemiological cut-of...